Loading chart…
LIVE
Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-hypertension, expectorant, anti-diabetics, anti-bacterial, anti-gout, anti asthmatics, quinolones, anti biotic, anti platelet, anti-histamines, and intermediates; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, and anti-mitotic.
Anuh Pharma Limited (ANUHPHR) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ANUHPHR share price is ₹80.69 (-0.32% today), with a market capitalisation of ₹8B and a price-to-earnings (P/E) ratio of 18.1. MarketRipple tracks the ANUHPHR investment thesis, the ripple-chain impact of market events on Anuh Pharma Limited, and the Healthcare sector outlook.
Open
₹81.60
High
₹82.78
Low
₹80.60
Prev. Close
₹80.95
52W High
₹99.50
52W Low
₹67.00
Day range
₹80.60–₹82.78
52-week range
₹67.00–₹99.50
Volume
13K
P/E
18.1
ROE
11.7%
D/E
0.00
Margin
5.7%
Anuh Pharma Limited (NSE: ANUHPHR) is currently trading at ₹80.69 (-0.32%).
Anuh Pharma Limited's market capitalization is ₹8B.
Anuh Pharma Limited's price-to-earnings (P/E) ratio is 18.1.
Anuh Pharma Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).